[esi adrotate group="1" cache="private" ttl="0"]

Update on cancer genetics, epigenetics and resulting therapeutics

Join us to understand how critically important the genetic and epigenetic changes in cancer are for disease biology and novel treatments.

There are 30 free bursary places available on a first come, first served basis. To claim your free place, please email us at [email protected].

Learning objectives include:

  • The role of genetic and epigenetic changes in cancer biology with examples of how this has already impacted patient treatment and survival
  • Novel emerging technologies such as gene-editing and radiomics to understand how these may lead to new therapies and predictors of response, respectively
  • Gain an insight into the trials and tribulations of genetic testing from a consumer point of view

This meeting will be relevant to clinical and medical oncologists, geneticists, basic scientists interested in cancer biology and genetics (cancer researchers), radiologist, pathologists, pharmacists, cancer researchers and cancer nurses, medical students and trainees interested in cancer and genetics.

A CPD certificate with CPD credit will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

Join in the conversation online
Follow us on Twitter: @RoySocMed 

Key Speakers:

Professor Alan Ashworth

E. Dixon Heise Distinguished Professor in Oncology, University of California San Francisco, President, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, Senior Vice President for Cancer Services,  University of California San Francisco Health, Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, United States of America

Professor Clare Scott

Professor of Gynaecological Cancer, University of Melbourne, Joint Head, Clinical Translation Centre, Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Medical Oncologist, Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women’s Hospitals, Australia

Professor Ian Tomlinson

Director, Cancer Research UK Edinburgh Centre, Charles and Ethel Barr Chair of Cancer Research

The Royal Society of Medicine

More in this category

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x